166 related articles for article (PubMed ID: 19954285)
1. ML17032 trial: capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in advanced gastric cancer.
Ryu MH; Kang YK
Expert Rev Anticancer Ther; 2009 Dec; 9(12):1745-51. PubMed ID: 19954285
[TBL] [Abstract][Full Text] [Related]
2. Capecitabine for the treatment of advanced gastric cancer.
Norman G; Soares M; Peura P; Rice S; Suh D; Wright K; Sculpher M; Eastwood A
Health Technol Assess; 2010 Oct; 14(Suppl. 2):11-7. PubMed ID: 21047486
[TBL] [Abstract][Full Text] [Related]
3. [Economic evaluation of capecitabine use as first line treatment in patients with advanced gastric carcinoma in Portugal].
Macedo A; Pereira C; Gonçalves J; Sousa C
Acta Med Port; 2009; 22(6):827-32. PubMed ID: 20350467
[TBL] [Abstract][Full Text] [Related]
4. [Capecitabine combined with cisplatin as first-line therapy in Chinese patients with advanced gastric carcinoma-a phase II clinical study].
Hu B; Yu JR; Wen ZZ; Shu YQ; Wang BC; Yin HR; Chen L; Bai YX; Liang J; Chen L; Cheng Y; Shen L; Zhou Y; Zhang HG; Li J; Wan DS; Chen S; Jia TZ; Jin ML
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):940-3. PubMed ID: 19173999
[TBL] [Abstract][Full Text] [Related]
5. Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study.
Ohtsu A; Shah MA; Van Cutsem E; Rha SY; Sawaki A; Park SR; Lim HY; Yamada Y; Wu J; Langer B; Starnawski M; Kang YK
J Clin Oncol; 2011 Oct; 29(30):3968-76. PubMed ID: 21844504
[TBL] [Abstract][Full Text] [Related]
6. Capecitabine plus oxaliplatin for the treatment of colorectal cancer.
Carrato A; Gallego-Plazas J; Guillén-Ponce C
Expert Rev Anticancer Ther; 2008 Feb; 8(2):161-74. PubMed ID: 18279056
[TBL] [Abstract][Full Text] [Related]
7. Review of capecitabine as oral treatment of gastric, gastroesophageal, and esophageal cancers.
Ajani J
Cancer; 2006 Jul; 107(2):221-31. PubMed ID: 16770784
[TBL] [Abstract][Full Text] [Related]
8. Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.
Norman G; Rice S; Spackman E; Stirk L; Danso-Appiah A; Suh D; Palmer S; Eastwood A
Health Technol Assess; 2011 May; 15 Suppl 1():33-42. PubMed ID: 21609651
[TBL] [Abstract][Full Text] [Related]
9. Capecitabine for the treatment of gastric cancer.
Kim TY; Oh DY; Bang YJ
Expert Rev Gastroenterol Hepatol; 2015; 9(12):1471-81. PubMed ID: 26470733
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma.
Li YH; Wang FH; Jiang WQ; Xiang XJ; Deng YM; Hu GQ; Xu DM; Chen Y; Lin Q; He YJ
Cancer Chemother Pharmacol; 2008 Aug; 62(3):539-44. PubMed ID: 18172651
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.
Lee SS; Lee JL; Ryu MH; Chang HM; Kim TW; Kang HJ; Kim WK; Lee JS; Kang YK
Jpn J Clin Oncol; 2007 Jan; 37(1):30-7. PubMed ID: 17272321
[TBL] [Abstract][Full Text] [Related]
12. Oral fluoropyrimidines (capecitabine or S-1) and cisplatin as first line treatment in elderly patients with advanced gastric cancer: a retrospective study.
Seol YM; Song MK; Choi YJ; Kim GH; Shin HJ; Song GA; Chung JS; Cho GJ
Jpn J Clin Oncol; 2009 Jan; 39(1):43-8. PubMed ID: 18997184
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer.
Kang YK; Ryu MH; Yoo C; Chang HM; Yook JH; Oh ST; Kim BS; Kim TW
Cancer Chemother Pharmacol; 2011 Jun; 67(6):1435-43. PubMed ID: 20811894
[TBL] [Abstract][Full Text] [Related]
14. [A case of recurrent gastric cancer showing partial response to capecitabine/CDDP after treatment with S-1/CDDP].
Goto A; Itoh M; Wakasugi H; Kanno S; Yabana T; Mitsuhashi K; Adachi T; Kondo Y; Suzuki T; Shinomura Y
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1563-6. PubMed ID: 23064073
[TBL] [Abstract][Full Text] [Related]
15. Modified docetaxel-cisplatin in combination with capecitabine as first-line treatment in metastatic gastric cancer. a phase II study.
Polyzos A; Felekouras E; Karatzas T; Griniatsos J; Dimitroulis D; Polyzos K; Kontzoglou K; Mantas D; Karavokyros J; Nikiteas N; Tsavaris N; Syrigos K; Vafiadis I
Anticancer Res; 2012 Sep; 32(9):4151-6. PubMed ID: 22993377
[TBL] [Abstract][Full Text] [Related]
16. Capecitabine and radiation therapy for advanced gastrointestinal malignancies.
Rich T
Oncology (Williston Park); 2002 Dec; 16(12 Suppl No 14):27-30. PubMed ID: 12520637
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of cisplatin and capecitabine in combination as first line treatment for unselected patients with advanced gastric cancer.
Viteri A; Muñoz A; Rubio I; Barceló R; Martínez-Bueno A; Fernández R; Carrera S; López-Vivanco G
Acta Oncol; 2007; 46(3):397-9. PubMed ID: 17450479
[No Abstract] [Full Text] [Related]
18. Capecitabine: a review.
Walko CM; Lindley C
Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of capecitabine plus cisplatin in patients with gastric cancer.
Salah-Eldin MA; Ebrahim MA; AL-Ashry MS
Anticancer Drugs; 2009 Mar; 20(3):191-6. PubMed ID: 19396018
[TBL] [Abstract][Full Text] [Related]
20. Significance of biological markers for predicting prognosis and selecting chemotherapy regimens of advanced gastric cancer patients between continuous infusion of 5-FU and a combination of 5-FU and cisplatin.
Boku N; Ohtsu A; Yoshida S; Shirao K; Shimada Y; Hyodo I; Saito H; Miyata Y;
Jpn J Clin Oncol; 2007 Apr; 37(4):275-81. PubMed ID: 17522103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]